Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications
Breast cancer ovarian metastases show increased activity of GPCR pathways.
Journal: bioRxiv : the preprint server for biology
Published: August 20, 2026
Mesenchymal stromal/stem cells in tumour initiation, progression and therapy.
Journal: Nature reviews. Cancer
Published: April 29, 2026
Prognostic Value of Lymphoid Infiltration and Aggregation in Cervical Cancer.
Journal: Cancers
Published: November 25, 2025
RHOV Is a Detachment-Responsive Rho GTPase Necessary for Ovarian Cancer Peritoneal Metastasis.
Journal: Cancer research
Published: September 08, 2025
The chemotherapy-induced senescence-associated secretome promotes cell detachment and metastatic dissemination through metabolic reprogramming.
Journal: bioRxiv : the preprint server for biology
Published: August 20, 2025
RHOV is a Detachment-Responsive Rho GTPase Necessary for Ovarian Cancer Peritoneal Metastasis.
Journal: bioRxiv : the preprint server for biology
Published: August 20, 2025
The chemotherapy-induced senescence-associated secretome promotes cell detachment and metastatic dissemination through metabolic reprogramming.
Journal: Nature aging
Published: August 12, 2025
Past failures and new horizons: the nuances of tertiary lymphoid structures in high-grade serous ovarian cancer may contribute to immunotherapy effectiveness.
Journal: Journal for immunotherapy of cancer
Published: April 01, 2025
Patient-reported outcomes from the MIRASOL trial evaluating mirvetuximab soravtansine versus chemotherapy in patients with folate receptor α-positive, platinum-resistant ovarian cancer: a randomised, open-label, phase 3 trial.
Journal: The Lancet. Oncology
Published: September 06, 2024
Stromal mediated DNA damage promotes high grade serous ovarian cancer initiation.
Journal: bioRxiv : the preprint server for biology
Published: June 10, 2024
Last Updated: 09/26/2026